Timothy Smokoff Sells Shares of Viemed Healthcare

On June 24, 2026, Timothy Smokoff sold 20,000 shares of Viemed Healthcare, Inc. (NasdaqCM: VMD) at an average price of $11.50 per share. The transaction was valued at $229,968.

Other Institutional Activity in Viemed Healthcare

In recent institutional activity, Vanguard Capital Management LLC opened a new position in Viemed Healthcare, acquiring 1,303,384 shares valued at approximately $12,004,167. Ameriprise Financial Inc. increased its stake by 75,506 shares, ending with 898,319 shares worth about $8,273,518. Forager Capital Management, LLC also grew its holdings by 40,000 shares, resulting in a total of 2,825,871 shares valued at $26,026,272. On the other hand, BlackRock, Inc. slightly reduced its position by 3,514 shares, maintaining a total of 4,622,562 shares valued at $42,573,795.

Viemed Healthcare, Inc. Stock Up 31.9%

Shares of Viemed Healthcare traded near $11.63 on Sunday. The company has a market cap of approximately $445.9 million and a P/E ratio of 31.43. Its stock has a 52-week low of $5.93 and a high of $11.88. The 50-day moving average is $9.89, while the 200-day moving average stands at $8.19. Viemed Healthcare maintains a current ratio of 1.22 and a quick ratio of 1.01, with a debt-to-equity ratio of 8.53.

Insider Buying and Selling at Viemed Healthcare, Inc.

In addition to Timothy Smokoff's sale, other insider transactions at Viemed Healthcare included William Frazier, Chief Medical Officer, who bought 10,000 shares at $1.81 on June 25, 2026, and sold 10,000 shares on the same day without a disclosed price. Michael Moore, President, sold 65,000 shares on March 20, 2026, at $8.77 and 40,232 shares on March 19, 2026, at $9.21.

Analysts Set New Price Targets

Lake Street reiterated its buy rating on Viemed Healthcare with a price target of $15.00 on May 7, 2024. The consensus among analysts is a buy rating with a mean price target of $11.00.

About Viemed Healthcare

Viemed Healthcare, Inc., based in Lafayette, Louisiana, provides home medical equipment and respiratory healthcare services across the United States. The company specializes in managing chronic respiratory diseases such as COPD, offering both invasive and non-invasive ventilation solutions. Viemed also provides sleep apnea management and testing, as well as other healthcare services. Led by CEO Mr. Casey Hoyt, the company employs around 1,387 people.

Bottom Line

Timothy Smokoff's recent sale of Viemed Healthcare shares is one of several insider activities at the company. Investors often track such transactions for insights, although they don't necessarily indicate future stock performance. Institutional movements, like Vanguard's new position, also provide context on market sentiment. As always, remember that insider and institutional actions are historical and may not reflect current positions.